focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 445.00
Bid: 430.00
Ask: 460.00
Change: 0.00 (0.00%)
Spread: 30.00 (6.977%)
Open: 445.00
High: 445.00
Low: 445.00
Prev. Close: 445.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jul 2016 07:00

RNS Number : 2623E
BrainJuicer Group PLC
15 July 2016
 

 

 

 

Press Release

15 July 2016

 

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer", or "the Company")

 

Six month Trading Update

 

BrainJuicer, the innovative international market research agency, today releases the following six month ("H1") trading update. The Company will announce its interim results for the six months to 30 June 2016 on 16 September 2016.

 

Top line growth during H1 was generally encouraging. Revenue increased by 13%, and by 9% in constant currencies, and gross profit (our main top-line performance indicator) grew by 15%, and 11% in constant currencies. Our largest market, the US, performed strongly, with gross profit rising by some 27%; gross profit in Continental Europe and Brazil also grew well, increasing by 30% and 22% respectively. Gross profit in our second largest market, the UK, declined by 2%, and in our China and Singapore region it also declined slightly by 5%.

 

Our Ad Testing and Brand Tracking services continued to grow strongly, with gross profit up 59% year on year. Much of this business is Ongoing in nature (as opposed to Ad Hoc), and builds on the "Fame, Feeling & Fluency" approach to brand building that we introduced last year.

 

After factoring in our new creative agency, System1, which was launched during H1 and, as anticipated, incurred costs of some £0.3m, BrainJuicer's operating profit increased by some 41% to around £1.7m. After adjusting for exceptional items (share based payments and also the one-off costs in H1 2015 relating to due diligence work and our Head Office move) normalized H1 pre-tax profit will be similar to the £1.7m reported in 2015.

 

BrainJuicer's financial position remains strong. At the end of June the Company had a cash balance of £5.2m (December 2015: £6.4m), after returning £2.2m to shareholders during H1 by way of dividends and share buy-backs.

The Company generates the majority of its annual profit in the second half of the year, and whilst our revenue visibility is, as ever, limited the Board believes that the Company is in a position to meet market expectations for the full year.

 

The decline in the value of sterling versus the US Dollar, the Euro and other leading currencies following the referendum on the UK's membership of the EU benefits the Company's non-UK profits reported in sterling. The results of our overseas businesses are translated into sterling using monthly average exchange rates. Beyond this, it is too early to say what the impact of the UK's exit from the EU on the market research budgets of our clients is likely to be.

 

This announcement contains inside information. The Company can be found at www.brainjuicer.com.

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSABRNWABAAR
Date   Source Headline
13th Jul 20117:00 amRNSTrading Update
28th Jun 20113:19 pmRNSTransaction in Own Shares
27th Jun 201110:37 amRNSDirector Dealing
20th Jun 20116:21 pmRNSTransaction in Own Shares
17th Jun 20114:39 pmRNSTransaction in Own Shares
7th Jun 20117:00 amRNSDirector Dealing
24th May 20114:32 pmRNSResult of AGM
12th May 201111:24 amRNSHolding(s) in Company
5th May 201112:36 pmRNSHolding(s) in Company
4th May 20114:34 pmRNSDirector Dealing
7th Apr 20115:57 pmRNSTransaction in Own Shares
4th Apr 20117:39 amRNSTransaction in Own Shares
24th Mar 20117:00 amRNSFinal Results
10th Mar 20119:24 amRNSBlocklisting Interim Review
21st Jan 20114:52 pmRNSHolding(s) in Company
14th Jan 20118:02 amRNSTrading Update
11th Jan 20116:10 pmRNSTransaction in Own Shares
26th Nov 20107:00 amRNSAppointment of Director
3rd Nov 20105:24 pmRNSHolding(s) in Company
22nd Oct 20108:33 amRNSHolding(s) in Company
22nd Oct 20108:33 amRNSHolding(s) in Company
12th Oct 20106:17 pmRNSTransaction in Own Shares
1st Oct 201012:23 pmRNSSubstantial Shareholder and Director Dealing
29th Sep 20105:48 pmRNSTransaction in Own Shares
22nd Sep 20107:00 amRNSInterim Results
10th Sep 20107:00 amRNSBlocklisting Interim Review
21st Jul 20101:22 pmRNSDirector Dealings
14th Jul 20108:14 amRNSTrading Update
28th May 201012:37 pmRNSTotal Voting Rights
18th May 20104:01 pmRNSTrading Update & Name change of Nomad and Broker
4th May 20105:52 pmRNSBlocklisting Application
22nd Apr 201012:17 pmRNSResults of Buyback Program and Director Dealing
22nd Apr 20107:00 amRNSBuyback Programme
31st Mar 201010:26 amRNSTotal Voting Rights
24th Mar 20101:22 pmRNSDirector/PDMR Shareholding
10th Mar 20103:11 pmRNSBlocklisting Interim Review
10th Mar 20103:05 pmRNS2009 Final Dividend
10th Mar 20107:38 amRNS2010 Interim Dividend
9th Mar 20107:00 amRNSFinal Results
1st Feb 20107:00 amRNSAlex Batchelor Appointed COO
19th Jan 20107:00 amRNSTrading Update
4th Jan 20102:10 pmRNSShare Dealings
22nd Sep 20097:00 amRNSInterim Dividend
22nd Sep 20097:00 amRNSInterim Results
1st Sep 20097:00 amRNSNotice of Results
8th Jul 200912:46 pmRNSShare Dealings
8th Jul 20097:00 amRNSTrading Statement
13th May 200910:20 amRNSResult of AGM
17th Apr 20097:00 amRNSNotice of AGM
16th Apr 20093:15 pmRNSFinal Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.